Coming Off the Antidepressant

I had been on sertraline for seven years when I started thinking seriously about coming off it.

I want to be careful about how I frame this, because the decision to taper an antidepressant is one that belongs entirely between a person and their prescriber, and I would not want anyone reading this to conclude that what worked for me is what they should do. My situation is specific. My history is specific. My prescriber was involved at every step. None of this happened because I read something on the internet and decided to act on it unilaterally.

That said, I think the honest account of what the process looked like is useful, because most of what is written about coming off antidepressants is either horror stories about withdrawal or cheerful optimism that glosses over the difficulty. Both are incomplete.

Why I wanted to come off

My depression was situational in origin. I went on sertraline after a period of significant loss, two bereavements close together and a business that nearly failed. The medication helped. There is no version of this story where the medication was the problem. It did its job.

Seven years later the original situation had changed. The grief had settled. The business had recovered. What remained was a flatness I had slowly come to associate with the medication itself, a leveling of affect that kept the lows manageable but also muted the highs. I talked to my prescriber about it. She agreed it was a reasonable thing to examine.

We decided to try a slow taper over six months. She reduced my dose by increments that were small enough that my nervous system had time to adjust. The process was not without difficulty. There were three weeks in month two that were harder than I expected, a return of anxiety I had forgotten I used to have. My prescriber and I were in contact regularly. We slowed the taper. The anxiety passed.

When microdosing entered the picture

I had been reading about microdosing for a couple of years, mostly with skepticism. I did not want to trade one daily pill for another. What shifted my thinking was a conversation with my prescriber, who had been following the Johns Hopkins and Imperial College research on psilocybin and depression. She was not recommending it, but she was not dismissing it either. She suggested that if I was going to try it, the sensible time to do so was after the taper was complete and my receptor sensitivity had had time to recover.

I waited four months after my last sertraline dose before beginning a microdose protocol. This was my prescriber's recommendation, based on the known timeline for 5-HT2A receptor upregulation after SSRI discontinuation. I am not certain four months is the right number for everyone. It is the number that made sense for my situation.

I started with Sacred Cybin's Daily at 100 mg and the Fadiman Protocol. My prescriber knew. I checked in with her at the one-week and four-week marks.

What the first cycle was like

The first cycle was quieter than I expected. The antidepressant had not been completely cleared from my system at a receptor level, my prescriber explained, even though the medication itself was gone. The first cycle I felt modest effects. A slight brightening. Nothing dramatic.

By the second cycle the effects were clearer. I noticed what I can only describe as emotional granularity returning. Not the highs and lows of untreated depression, which in my case had been mostly lows, but a fuller range of ordinary feeling. Sadness when something was sad. Satisfaction when something went well. A connection to my own reactions that the medicated years had smoothed over.

I am eighteen months out from my last sertraline dose and on my fifth microdose cycle. I have not returned to antidepressants. I do not know whether I will need to in the future, and I am trying to hold that uncertainty without it being a threat.

What I want to be clear about

I am not suggesting that coming off antidepressants is the right move for anyone else. For many people, SSRIs are a necessary, long-term, possibly permanent part of mental health management. The research on psilocybin as a support during or after SSRI discontinuation is genuinely early-stage. My experience is one data point, not a protocol.

If you are on an antidepressant and thinking about this, the conversation to have is with your prescriber. Not with Reddit, not with a podcast, not with this blog. With your doctor, who knows your history. Bring them the research if they are not familiar with it. Ask the questions you are afraid to ask. The conversation is worth having, even if the answer is not to change anything.

The thing I most want to pass on is not a recommendation but an observation. The process of attending carefully to your own mental states, which microdosing invites through its emphasis on daily tracking and integration, is useful regardless of what you decide about medication. Paying attention to yourself is its own kind of medicine.